YORK, Pa., Jan. 7, 2011 (GLOBE NEWSWIRE) -- GlaxoSmithKline (GSK) and DENTSPLY International (Nasdaq:XRAY), a global leader in professional dental products, today announced that they have entered into an agreement to create a portfolio of co-branded oral care products to be used in the dental office by patients suffering from tooth sensitivity, a problem which is estimated to affect 1 in 3 people.
